• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Inflammatory Response and Treatment-Resistant Mental Disorders: Should Immunotherapy Be Added to Pharmacotherapy?

作者信息

Limandri Barbara J

出版信息

J Psychosoc Nurs Ment Health Serv. 2020 Jan 1;58(1):11-16. doi: 10.3928/02793695-20191218-03.

DOI:10.3928/02793695-20191218-03
PMID:31895965
Abstract

Treatment resistance continues to challenge and frustrate mental health clinicians and provoke psychiatric researchers to seek additional explanatory theories for psychopathology. Because the inflammatory process activates symptoms of depression, anxiety, and psychosis, it is a reasonable route to follow for primary and/or indirect contribution to mental disorders. The current article reviews the research literature regarding the role the inflammatory process and immune system play in mental disorders as well as novel treatments under investigation for resistant depression, anxiety, substance use, and psychotic disorders. [Journal of Psychosocial Nursing and Mental Health Services, 58(1), 11-16.].

摘要

相似文献

1
Inflammatory Response and Treatment-Resistant Mental Disorders: Should Immunotherapy Be Added to Pharmacotherapy?
J Psychosoc Nurs Ment Health Serv. 2020 Jan 1;58(1):11-16. doi: 10.3928/02793695-20191218-03.
2
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.精准医疗,首次就诊:高度个性化和基于评估的青少年心理健康管理医疗模式。
Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383.
3
Psychoneuroimmunology of mental disorders.精神障碍的心理神经免疫学
Rev Psiquiatr Salud Ment (Engl Ed). 2018 Apr-Jun;11(2):115-124. doi: 10.1016/j.rpsm.2017.07.006. Epub 2017 Oct 6.
4
Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.治疗精神分裂症或抑郁症患者的大麻使用问题:系统评价。
J Clin Psychiatry. 2010 Mar;71(3):247-54. doi: 10.4088/JCP.09r05119gry.
5
Coproducing healthcare service improvement for people with common mental health disorders including psychotic experiences: a study protocol of a multiperspective qualitative study.共同生产常见精神健康障碍(包括精神病性体验)患者的医疗服务改进:一项多视角定性研究的研究方案。
BMJ Open. 2018 Nov 8;8(11):e026064. doi: 10.1136/bmjopen-2018-026064.
6
The chronically mentally ill in primary care.基层医疗中的慢性精神病患者。
Psychol Med. 1985 May;15(2):265-73. doi: 10.1017/s0033291700023540.
7
Integrating psychological and pharmacological treatment of dually diagnosed patients.
NIDA Res Monogr. 1995;150:110-28.
8
Comorbidity among anxiety disorders: implications for treatment and DSM-IV.焦虑症中的共病现象:对治疗及《精神疾病诊断与统计手册第四版》的启示
J Consult Clin Psychol. 1992 Dec;60(6):835-44. doi: 10.1037//0022-006x.60.6.835.
9
Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders.增强型可塑性心理疗法治疗难治性抑郁和焦虑障碍。
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:134-47. doi: 10.1016/j.pnpbp.2016.04.003. Epub 2016 Apr 9.
10
[Alpha-interferon and mental disorders].[α-干扰素与精神障碍]
Encephale. 2001 Jul-Aug;27(4):308-17.